Abstract
To investigate the pharmacokinetic behavior of clonidine, rats were given clonidine intravenously at 125, 250, and 500μg/kg and blood clonidine concentrations were followed for 6 hr. The disposition of clonidine in two brain regions was studied in rats after an i. v. dose of 500 μg/kg. The liver clearance in rats was investigated by liver perfusion techniques. The results obtained indicate that the disposition characteristics of clonidine can be described by a two-compartment open model in both rats and cats. The penetration of clonidine into tissues is rapid, and brain levels in rats were about 1.7 times higher than blood levels. Brain tissues were found to be an indistinguisible part of the central (blood) compartment. Dose-dependent pharmacokinetic behavior was found for clonidine in rats at the doses used. This was demonstrated by a decrease of both the rate constant of distribution to the peripheral compartment and the overall elimination rate constant from the body, with increase in dose. As a consequence, the volume of distribution and the clearance both decreased with increasing dose. Possible explanations for the dose-dependent behavior of clonidine are discussed.
Similar content being viewed by others
References
W. Hoefke and W. Kobinger. Pharmakologische Wirkungen des 2-(2,6-Dichlorphenyl-amino)-2-imidazolinhydrochlorids, einer neuen, antihypertensiven Substanz.Arzneim.-Forsch. 16:1038–1050 (1966).
W. Kobinger and A. Walland. Investigations into the mechanism of the hypotensive effect of 2-(2,6-dichlorphenylamino)-2-imidazoline-HCl.Eur. J. Pharmacol. 2:155–162 (1967).
K. D. Bock, V. Heimsoth, P. Merguet, and J. Schönermark. Klinische und klinisch-experimentelle Untersuchungen mit einer neuen blutdrucksenkenden Substanz: Dichlorphenylaminoimidazolin.Deutsch. Med. Wochenschr. 91:1761–1770 (1966).
W. Kobinger. In O. Onesti, K. E. Kim, and I. J. Meyer (eds.),Hypertension Mechanisms and Managements, Grune and Stratton, New York, 1973, pp. 369–382.
R. W. Sattler and P. A. van Zwieten. Acute hypotensive action of 2-(2,6-dichlorophenyl-amino)-2-imidazoline hydrochloride (ST 155) after infusion into the cat's vertebral artery.Eur. J. Pharmacol. 2:9–13 (1967).
H. Schmitt, H. Schmitt, J. R. Boissier, J. F. Giudicelli, and J. Fichelle. Cardiovascular effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST 155).Eur. J. Pharmacol. 2:340–346 (1968).
P. Bolme and K. Fuxe. Pharmacological studies on the hypotensive effects of clonidine.Eur. J. Pharmacol. 13:168–174 (1971).
G. Haeusler. Further similarities between the action of clonidine and a central activation of the depressor baroreceptor reflex.Naunyn-Schmiedeberg's Arch. Pharmacol. 285:1–14 (1974).
H. Brüner and K. E. Klein. In L. Heilmeyer, H. J. Holtmeier, and E. F. Pfeiffer (eds.),Hochdruck-therapie, G. Thieme, Stuttgart, 1968, pp. 180–184.
B. Delbarre and H. Schmitt. Sedative effects of α-sympathomimetic drugs and their antagonism by adrenergic and cholinergic blocking drugs.Eur. J. Pharmacol. 13:356–363 (1971).
L. Paalzow. Analgesia produced by clonidine in mice and rats.J. Pharm. Pharmacol. 26:361–363 (1974).
H. Schmitt, J.-C. Le Douraec, and N. Petillot. Antinociceptive effects of someα-sympathomimetic agents.Neuropharmacology 13:289–294 (1974).
G. Paalzow and L. Paalzow. Clonidine antinociceptive activity: Effects of drugs influencing central monoaminergic and cholinergic mechanisms in the rat.Naunyn-Schmiedeberg's Arch. Pharmacol. 292:119–126 (1976).
A. K. Cho and S. H. Curry. The physiological disposition of 2-(2,6-dichloroanilino)-2-imidazoline (ST 155).Biochem. Pharmacol. 18:511–520 (1969).
D. Rehbinder. In A. Zanchetti and M. Enrico (eds.),Ipertensione Arteriosa, Boehringer Ingelheim, Firenze, 1973, pp. 3–22.
C. T. Dollery, D. S. Davies, G. H. Draffan, H. J. Dargie, C. R. Dean, J. L. Reid, R. A. Clare, and S. Murray. Clinical pharmacology and pharmacokinetics of clonidine.Clin. Pharmacol. Ther. 19:11–17 (1976).
D. S. Davies, L. M. H. Wing, J. L. Reid, E. Neill, P. Tippett, and C. T. Dollery. Pharmacokinetics and concentration-effect relationships of intravenous and oral clonidine.Clin. Pharmacol. Ther. 21:593–601 (1977).
P. O. Edlund and L. K. Paalzow. Quantitative gas-liquid chromatographic determination of clonidine in plasma.Acta Pharmacol. Toxicol. 40:145–152 (1977).
R. A. Upton. Simple and reliable method for serial sampling of blood from rats.J. Pharm. Sci. 64:112–114 (1975).
J. Glowinski and L. L. Iversen. Regional studies of catecholamines in the rat brain. I.J. Neurochem. 13:655–669 (1966).
G. Paalzow. The potential role of catecholamines in drug induced changes of central pain responses, with special emphasis on morphine effects in the rat.Acta Univ. Upsaliens. 9:1–45 (1976).
R. Hems, B. D. Ross, M. N. Berry, and H. A. Krebs. Gluconeogenesis in the perfused rat liver.Biochem. J. 101:284–292 (1966).
B. E. Dahlström, J. Jonsson, and L. K. Paalzow. Metabolism of morphine in the perfused rat liver.Acta Pharmacol. Toxicol. 39:46–52 (1976).
K. S. Pang and M. Rowland. Hepatic clearance of drugs. I. Theoretical considerations of a “well-stirred” model and a “parallel tube” model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance.J. Phamacokin. Biopharm. 5:625–653 (1977).
W. J. Jusko and M. Gibaldi. Effects of change in elimination on various parameters of the two-compartment open model.J. Pharm. Sci. 61:1270–1273 (1972).
L. Paalzow and P. O. Edlund. Multiple receptor responses: A new concept to describe the relationship between pharmacological effects and pharmacokinetics of a drug. Studies on clonidine in the rat and cat.J. Pharmacokin. Biopharm. 7:495–510 (1979).
G. Haeusler. Studies on the possible contribution of a peripheral presynaptic action of clonidine and dopamine to their vascular effects underin vivo conditions.Naunyn-Schmiedeberg's Arch. Pharmacol. 295:191–202 (1976).
H. Ozawa, C.-S. Chen, H. Watanabe, and T. Uematsu. Effect of clonidine on blood pressure, heart rate and body temperature in conscious rats.Jpn. J. Pharmacol. 27:47–54 (1977).
M. Rowland, L. Z. Benet, and G. G. Graham. Clearance concepts in pharmacokinetics.J. Pharmacokin. Biopharm. 1:123–136 (1973).
G. R. Wilkinson. Pharmacokinetics of drug disposition hemodynamic considerations.Ann. Rev. Pharmacol. 15:11–27 (1975).
J. G. Wagner.Fundamentals of Clinical Pharmacokinetics, Drug Intelligence Publications, Hamilton, Ill, 1975, pp. 82–85.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Paalzow, L.K., Edlund, P.O. Pharmacokinetics of clonidine in the rat and cat. Journal of Pharmacokinetics and Biopharmaceutics 7, 481–494 (1979). https://doi.org/10.1007/BF01062390
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01062390